{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T02:46:13Z","timestamp":1770777973603,"version":"3.50.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.11.051","type":"journal-article","created":{"date-parts":[[2009,12,9]],"date-time":"2009-12-09T07:27:06Z","timestamp":1260343626000},"page":"1451-1453","source":"Crossref","is-referenced-by-count":24,"title":["Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever"],"prefix":"10.1016","volume":"28","author":[{"given":"James E.","family":"Froeschle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.vaccine.2009.11.051_bib1","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"New Engl J Med"},{"issue":"21","key":"10.1016\/j.vaccine.2009.11.051_bib2","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1001\/archinte.1995.00430210041007","article-title":"A new typhoid vaccine composed of the Vi capsular polysaccharide","volume":"155","author":"Plotkin","year":"1995","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.051_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2310\/7060.2005.12604","article-title":"Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years","volume":"12","author":"Overbosch","year":"2005","journal-title":"J Travel Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.051_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/421945","article-title":"Typhoid fever in travelers: who should be targeted for prevention?","volume":"39","author":"Steinberg","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.11.051_bib5","unstructured":"Typhim Vi\u00ae, Typhoid Vi polysaccharide vaccine [prescribing information]. Lyon, France: Sanofi Pasteur SA; 2005."},{"issue":"9","key":"10.1016\/j.vaccine.2009.11.051_bib6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s100960050361","article-title":"Experience with Salmonella typhi Vi capsular polysaccharide vaccine","volume":"18","author":"Hessel","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2009.11.051_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0264-410X(95)00186-5","article-title":"Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization","volume":"14","author":"Klugman","year":"1996","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.051_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0264-410X(94)90194-5","article-title":"Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines","volume":"12","author":"Keitel","year":"1994","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.051_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1708-8305.2007.00158.x","article-title":"Safety of Typhim Vi vaccine in a postmarketing observational study","volume":"14","author":"Marcus","year":"2007","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2009.11.051_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1086\/381548","article-title":"Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System. July 1990 through June 2002","volume":"38","author":"Begier","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2009.11.051_bib11","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJM198710293171801","article-title":"Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report","volume":"317","author":"Acharya","year":"1987","journal-title":"N Engl J Med"},{"issue":"8569","key":"10.1016\/j.vaccine.2009.11.051_bib12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(87)91316-X","article-title":"Protective activity of Vi capsular polysaccharide vaccine against typhoid fever","volume":"2","author":"Klugman","year":"1987","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.051_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0264-410X(98)00160-1","article-title":"Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization","volume":"17","author":"Keddy","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.11.051_bib14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10654-005-7454-6","article-title":"Outbreak of typhoid fever in vaccinated members of the French Armed Forces in the Ivory Coast","volume":"20","author":"Michel","year":"2005","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.051_bib15","first-page":"49","article-title":"Typhoid vaccines: WHO position paper","volume":"83","author":"World Health Organization","year":"2008","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09018544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09018544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T13:59:26Z","timestamp":1544795966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09018544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X09018544"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}